Ingenol Mebutate and the Treatment of Actinic Keratosis

J Drugs Dermatol. 2021 Jan 1;20(1):102-104. doi: 10.36849/JDD.5328.

Abstract

Actinic keratoses (AKs) are common skin lesions association with increased exposure to ultraviolet radiation; these lesions have the potential to transform into squamous cell carcinomas (SCCs).1.

Publication types

  • Editorial

MeSH terms

  • Aminolevulinic Acid / administration & dosage
  • Aminolevulinic Acid / adverse effects
  • Aminolevulinic Acid / analogs & derivatives
  • Carcinoma, Squamous Cell / epidemiology
  • Carcinoma, Squamous Cell / etiology
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / prevention & control*
  • Clinical Trials as Topic
  • Diterpenes / administration & dosage
  • Diterpenes / adverse effects*
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects
  • Humans
  • Imiquimod / administration & dosage
  • Imiquimod / adverse effects
  • Incidence
  • Keratosis, Actinic / pathology
  • Keratosis, Actinic / therapy*
  • Patient Preference
  • Photochemotherapy / methods
  • Photosensitizing Agents / administration & dosage
  • Photosensitizing Agents / adverse effects
  • Risk Assessment / statistics & numerical data
  • Skin Neoplasms / epidemiology
  • Skin Neoplasms / etiology
  • Skin Neoplasms / pathology
  • Skin Neoplasms / prevention & control*
  • Treatment Outcome

Substances

  • 3-ingenyl angelate
  • Diterpenes
  • Photosensitizing Agents
  • methyl 5-aminolevulinate
  • Aminolevulinic Acid
  • Imiquimod
  • Fluorouracil